Pluri (PLUR) Total Current Liabilities (2011 - 2025)
Pluri (PLUR) reported Total Current Liabilities of $32.3 million for Q4 2025, up 628.51% year-over-year from $4.4 million in Q4 2024, and up 0.58% quarter-over-quarter from $32.2 million in Q3 2025.
Pluri (PLUR) Total Current Liabilities (2011 - 2025) Analysis & Trends
Pluri (PLUR) has 15 years of Total Current Liabilities data on file, last reported at $32.3 million in Q4 2025.
- Total Current Liabilities for Q4 2025 came in at $32.3 million, up 628.51% year-over-year; the trailing twelve-month figure through Dec 2025 was $32.3 million (up 628.51% YoY), and the FY2025 annual result was $32.3 million, up 625.82% from the prior year.
- Total Current Liabilities advanced to $32.3 million in Q4 2025 per PLUR's latest filing, from $32.2 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $32.3 million in Q4 2025 and troughed at $4.3 million in Q3 2023.
- A 5-year average of $10.3 million and a median of $5.7 million in 2023 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Current Liabilities slumped 51.59% in 2022, then jumped 628.51% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $9.6 million in 2021, then slumped by 44.93% to $5.3 million in 2022, then fell by 14.27% to $4.5 million in 2023, then slipped by 1.99% to $4.4 million in 2024, then jumped by 628.51% to $32.3 million in 2025.
- Business Quant data shows PLUR's Total Current Liabilities at $32.3 million in Q4 2025, $32.2 million in Q3 2025, and $32.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 13.42 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 72.86 Mn |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | 32.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 32.35 Mn |
| Sep 30, 2025 | 32.16 Mn |
| Jun 30, 2025 | 32.33 Mn |
| Mar 31, 2025 | 5.71 Mn |
| Dec 31, 2024 | 4.44 Mn |
| Sep 30, 2024 | 4.58 Mn |
| Jun 30, 2024 | 4.45 Mn |
| Mar 31, 2024 | 4.53 Mn |
| Dec 31, 2023 | 4.53 Mn |
| Sep 30, 2023 | 4.32 Mn |
| Jun 30, 2023 | 5.62 Mn |
| Mar 31, 2023 | 5.38 Mn |
| Dec 31, 2022 | 5.28 Mn |
| Sep 30, 2022 | 5.02 Mn |
| Jun 30, 2022 | 6.83 Mn |
| Mar 31, 2022 | 7.82 Mn |
| Dec 31, 2021 | 9.60 Mn |
| Sep 30, 2021 | 10.37 Mn |
| Jun 30, 2021 | 11.52 Mn |
| Mar 31, 2021 | 9.92 Mn |